ArticlePloS one2018

Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.

Maria Giuseppa Vitale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.